CDKN1B and cancer: Studies in that cancer suggested that TM4SF5 could enhance p27Kip1 expression and phosphorylation and lead to epithelial-mesenchymal transition (EMT) to mediate tumorigenesis, metastasis and gefitinib resistance [36–39].